Influcid (Tablets) Instructions for Use

Marketing Authorization Holder

Alpen Pharma, GmbH (Germany)

Contact Information

German Homeopathic Union (Germany)

ATC Code

R05X (Other remedies for the treatment of colds)

Dosage Form

Influcid

Lozenges: 60 pcs.

Dosage Form, Packaging, and Composition

Tablets for resorption from white to slightly white-yellow in color, round, flat, with a beveled edge.

Excipients: lactose monohydrate, magnesium stearate, wheat starch.

20 pcs. – blisters (3) – cardboard packs.

Oral solution transparent, light yellow, with an alcohol odor, and a weak spicy sweetish taste.

Excipients: Eucalyptus globulusØ, ethanol 96%, purified water. Alcohol content – 45% by volume.

30 ml – dark glass dropper bottles (1) – cardboard packs.

Clinical-Pharmacological Group

Homeopathic preparation used for colds

Pharmacotherapeutic Group

Homeopathic agent

Pharmacological Action

A homeopathic preparation used for colds. It has anti-inflammatory, antipyretic, expectorant, and mucolytic effects. It helps to strengthen immunity.

Pharmacokinetics

The pharmacokinetics of the drug Influcid have not been studied.

Indications

• Prevention and treatment of influenza and other acute respiratory viral infections (ARVI).

ICD codes

Dosage Regimen

For acute illness, children from 3 to 6 years are prescribed 1 tablet every 2 hours (no more than 6 times/day) until improvement occurs, then – 1/2 tablet 3 times/day until complete recovery.

Children from 6 to 12 years are prescribed 1 tablet every hour (no more than 7-8 times/day) until improvement occurs, then – 1 tablet 3 times/day until complete recovery.

Adults and children over 12 years are prescribed 1 tablet every hour (no more than 12 times/day) until improvement occurs, then – 1-2 tablets 3 times/day until complete recovery.

The drug in the form of an oral solution for acute illnesses is prescribed as 10 drops every hour (no more than 12 times/day) until improvement occurs, then – 10-20 drops 3 times/day until complete recovery.

For the prevention of ARVI, children from 3 to 6 years are prescribed 1/2 tablet 2 times/day; children from 6 to 12 years – 1 tablet 2 times/day; adults and children over 12 years are prescribed 1 tablet 3 times/day.

For the prevention of ARVI, the drug in the form of an oral solution is prescribed to adults and children over 12 years as 10-20 drops 3 times/day.

The drug should be taken 30 minutes before or 30 minutes after a meal. The tablets should be slowly dissolved in the mouth. For children from 3 to 5 years, it is recommended to dissolve the tablet in a small amount of liquid or give it in crushed form under the tongue.

Adverse Reactions

Possible allergic reactions.

Contraindications

• Hypersensitivity to the components of the drug.

It is not recommended to prescribe the drug in tablet form to children under 3 years of age (due to insufficient clinical data).

Use in Pregnancy and Lactation

The use of the drug Influcid during pregnancy and lactation (breastfeeding) is possible only if the intended benefit to the mother outweighs the potential risk to the fetus and child.

Pediatric Use

It is not recommended to prescribe the drug in tablet form to children under 3 years of age (due to insufficient clinical data).

For acute illness, children from 3 to 6 years are prescribed 1 tablet every 2 hours (no more than 6 times/day) until improvement occurs, then – 1/2 tablet 3 times/day until complete recovery.

Children from 6 to 12 years are prescribed 1 tablet every hour (no more than 7-8 times/day) until improvement occurs, then – 1 tablet 3 times/day until complete recovery.

Adults and children over 12 years are prescribed 1 tablet every hour (no more than 12 times/day) until improvement occurs, then – 1-2 tablets 3 times/day until complete recovery.

For the prevention of ARVI, children from 3 to 6 years are prescribed 1/2 tablet 2 times/day; children from 6 to 12 years – 1 tablet 2 times/day; children over 12 years are prescribed 1 tablet 3 times/day.

For the prevention of ARVI, the drug in the form of an oral solution is prescribed to children over 12 years as 10-20 drops 3 times/day.

Special Precautions

When using Influcid, a temporary worsening of the condition is possible. In this case, the patient should stop taking the drug and consult a doctor.

When using Influcid, the use of other medications is allowed.

The patient should be informed that if there is no improvement in the acute illness after 2 days, the drug should be discontinued and a doctor should be consulted.

Taking the drug Influcid in tablet form may have a negative effect on patients with celiac disease and lactose intolerance. Such patients are recommended to take the drug in the form of an oral solution.

Overdose

Currently, no cases of overdose with the drug Influcid have been reported.

Drug Interactions

Drug interactions of the drug Influcid with other medicinal products have not been established.

Storage Conditions

The drug in tablet form should be stored in a dry place, out of the reach of children, at a temperature of 15°-25°C (59°-77°F).

The drug in the form of an oral solution should be stored in a dry place, out of the reach of children, at room temperature.

Shelf Life

The shelf life of the drug in tablet form is 3 years, in the form of an oral solution – 5 years.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.